12 research outputs found
La transformation de la professionnalité des enseignants : quel rÎle du prescrit ?
International audienceRĂ©sumĂ© Les injonctions institutionnelles supposent des ajustements dans le travail des enseignants. Le processus dâadaptation aux rĂ©formes et ses effets sur leur professionnalitĂ© sont interrogĂ©s Ă partir de deux Ă©tudes de cas situĂ©es dans deux univers professionnels distincts : le collĂšge de la scolaritĂ© obligatoire et lâuniversitĂ© de masse. Les rĂ©sultats des deux enquĂȘtes montrent que dâautres Ă©lĂ©ments que le prescrit interviennent dans les transformations de la professionnalitĂ©. Un processus de crĂ©ation de normes intermĂ©diaires rĂ©sultant dâune traduction du prescrit en lien avec lâenvironnement de travail (notamment les dispositifs sociotechniques) joue un rĂŽle dĂ©terminant
Surveillance du cancer du sein (une évolution : plaidoyer pour un mode alterné incluant le médecin traitant)
LYON1-BU Santé (693882101) / SudocSudocFranceF
Quality of life in patients with non-metastatic breast cancer: evolution during follow-up and vulnerability factors
International audienceObjective In women with breast cancer, many disease-related psychosocial factors directly affect quality of life (QoL) during and after treatment. The aims of this prospective study were to evaluate the psychosocial factors affecting QoL and its dimensions, to study their evolution over time, and to determine the factors associated with this evolution.Methods Thirty women with non-metastatic breast cancer were asked to complete a number of questionnaires evaluating QoL and its dimensions, symptoms of anxiety and depression, body image, social support, and coping strategies immediately after their diagnosis of breast cancer (T1), at the end of treatment (T2), and 6 months after the end of treatment (T3).Results Level of education, mastectomy, and hormonotherapy all had an impact on QoL. QoL and its dimensions changed over time. Coping strategies, social support, body image, and symptoms of anxiety and depression were predictive factors for QoL.Conclusion The identification of these predictive factors should help medical teams to identify the patients who are most vulnerable and susceptible to poor QoL. In women with breast cancer, it is essential to identify and treat any changes in patients' need for support in an appropriate manner, both during the course of therapy and particularly during remission
Quality of life in patients with non-metastatic breast cancer: evolution during follow-up and vulnerability factors
International audienceObjective: In women with breast cancer, many disease-related psychosocial factors directly affect quality of life (QoL) during and after treatment. The aims of this prospective study were to evaluate the psychosocial factors affecting QoL and its dimensions, to study their evolution over time, and to determine the factors associated with this evolution.Methods Thirty women with non-metastatic breast cancer were asked to complete a number of questionnaires evaluating QoL and its dimensions, symptoms of anxiety and depression, body image, social support, and coping strategies immediately after their diagnosis of breast cancer (T1), at the end of treatment (T2), and 6 months after the end of treatment (T3).Results: Level of education, mastectomy, and hormonotherapy all had an impact on QoL. QoL and its dimensions changed over time. Coping strategies, social support, body image, and symptoms of anxiety and depression were predictive factors for QoL.Conclusion: The identification of these predictive factors should help medical teams to identify the patients who are most vulnerable and susceptible to poor QoL. In women with breast cancer, it is essential to identify and treat any changes in patients' need for support in an appropriate manner, both during the course of therapy and particularly during remission
Le récit du commun
Cet ouvrage collectif prĂ©sente les rĂ©sultats dâune enquĂȘte internationale menĂ©e auprĂšs dâenviron 7 000 Ă©lĂšves ĂągĂ©s de 11 Ă 19 ans, Ă qui il a Ă©tĂ© demandĂ© de raconter lâhistoire nationale. Des Ă©lĂšves français, suisses, catalans, allemands ont rĂ©pondu Ă un questionnaire et racontĂ© librement « leur » histoire nationale. Contre les idĂ©es reçues dâun manque de connaissances historiques et de lâabsence de tout rĂ©cit commun, lâenquĂȘte dĂ©voile des formes de narration, des organisateurs du rĂ©cit et des contenus partagĂ©s, une vĂ©ritable trame commune. Lâanalyse de ces formes et contenus prĂ©cise leurs points forts, mais aussi les absences ou les spĂ©cificitĂ©s nationales, et montre comment les savoirs scolaires coexistent avec dâautres sources de connaissances. Sont Ă©tudiĂ©es en particulier les places respectives et les fonctions du politique, de la religion, de la guerre, dans ces rĂ©cits qui tĂ©moignent dâun imaginaire national. Un effet « territorial » est enfin mis en valeur, Ă la fois moins important que prĂ©vu en France et significatif Ă lâĂ©chelle des pays. Sensibles au contexte, ces rĂ©cits sont la manifestation juvĂ©nile dâune conscience historique en formation, qui sâexprime selon des formes inĂ©dites
Les échelles de la mémoire en Méditerranée
International audienceDepuis les annĂ©es 1980, les liens entre histoire et mĂ©moire sont rĂ©guliĂšrement interrogĂ©s lors de dĂ©bats tant scientifiques que publics ou politiques. Si le sujet passionne la France - les polĂ©miques relatives aux « lois mĂ©morielles », au passĂ© colonial ou à « lâidentitĂ© nationale »en tĂ©moignent -, il est encore peu Ă©tudiĂ© Ă lâaune de lâespace mĂ©diterranĂ©en. Force est de constater une multiplication des revendications et des conflits dont les enjeux sont lâaffirmation ou la redĂ©finition des identitĂ©s - enjeux indissociables dâun vĂ©ritable « travail de mĂ©moire », câest-Ă -dire un travail de dĂ©voilement dâun « passĂ© qui ne passe pas » (le gĂ©nocide armĂ©nien, la purification ethnique en Palestine ou en Bosnie, la colonisationâŠ). Lâinstrumentalisation du passĂ© Ă des fins politiques nâest pas une spĂ©cificitĂ© mĂ©diterranĂ©enne, mais elle a pris dans cet espace aux identitĂ©s fragilesune coloration particuliĂšrement vive. Ainsi, des Balkans au Proche-Orient en passant par le Maghreb, la confrontation entre les diffĂ©rentes Ă©chelles de mĂ©moire - Ă©tatique ou collective, officielle ou marginalisĂ©e - concourt Ă exacerber les antagonismes. Cet ouvrage qui rassemble des contributions dâanthropologues, dâhistoriens, de gĂ©ographes, dâarchĂ©ologues et de politologues interroge les mĂ©canismes de fabrication de ces hĂ©ritages qui divisent ou rapprochent les hommes au sein dâun mĂȘme espace
Overview of the pathological results and treatment characteristics in the first 1000 patients randomized in the SERC trial: axillary dissection versus no axillary dissection in patients with involved sentinel node
Abstract Background Three randomized trials have concluded at non inferiority of omission of complementary axillary lymph node dissection (cALND) for patients with involved sentinel node (SN). However, we can outline strong limitations of these trials to validate this attitude with a high scientific level. We designed the SERC randomized trial (ClinicalTrials.gov, number NCT01717131) to compare outcomes in patients with SN involvement treated with ALND or no further axillary treatment. The aim of this study was to analyze results of the first 1000 patients included. Methods SERC trial is a multicenter non-inferiority phase 3 trial. Multivariate logistic regression analysis was used to identify independent factors associated with adjuvant chemotherapy administration and non-sentinel node (NSN) involvement. Results Of the 963 patients included in the analysis set, 478 were randomized to receive cALND and 485 SLNB alone. All patient demographics and tumor characteristics were balanced between the two arms. SN ITC was present in 6.3% patients (57/903), micro metastases in 33.0% (298), macro metastases in 60.7% (548) and 289 (34.2%) were non eligible to Z0011 trial criteria. Whole breast or chest wall irradiation was delivered in 95.9% (896/934) of patients, adjuvant chemotherapy in 69.5% (644/926), endocrine therapy in 89.6% (673/751) and the proportions were similar in the two arms. The overall rate of positive NSN was 19% (84/442) for patients with cALND. Crude rates of positive NSN according to SN status were 4.5% for ITC (1/22), 9.5% for micro metastases (13/137), 23.9% for macro metastases (61/255) and were respectively 29.36% (64/218), 9.33% (7/75) and 7.94% (10/126) when chemotherapy was administered after cALND, before cALND and for patients without chemotherapy. Conclusion The main objective of SERC trial is to demonstrate non inferiority of cALND omission. A strong interaction between timing of cALND and chemotherapy with positive NSN rate was observed. Trial registration This study is registered with ClinicalTrials.gov, number NCT01717131 October 19, 2012